This idea may be plausible if we were to take into account that there is a recent report showing that CD4+NKG2D+ T cells represent a key source of IL-17 in patients with Crohn’s disease and that these cells share a Th17-related phenotype, including high expression of the cytotoxicity marker CD161 [6]. Here, IL17A is linked to Crohn disease.